Provided by Tiger Trade Technology Pte. Ltd.

Achieve Life Sciences, Inc.

7.53
-0.5600-6.92%
Post-market: 7.570.0400+0.53%19:49 EDT
Volume:1.15M
Turnover:8.87M
Market Cap:773.02M
PE:-4.54
High:8.04
Open:7.89
Low:7.52
Close:8.09
52wk High:8.64
52wk Low:2.62
Shares:102.66M
Float Shares:74.69M
Volume Ratio:0.79
T/O Rate:1.54%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6600
EPS(LYR):-1.2535
ROE:-844.99%
ROA:-29.21%
PB:-52.67
PE(LYR):-6.01

Loading ...

US FDA declines to approve Achieve Life Sciences' smoking-cessation drug

Reuters
·
Jun 22

Achieve Life Sciences gets FDA complete response letter for cytisinicline NDA over manufacturing deficiencies

Reuters
·
Jun 22

Achieve Life Sciences - FDA Crl Cites Manufacturing Observations and Incomplete Product Labeling

THOMSON REUTERS
·
Jun 22

Achieve Life Sciences Receives Complete Response Letter From FDA for Cytisinicline Nda

THOMSON REUTERS
·
Jun 22

Achieve Life Sciences - FDA Identifies No Deficiencies in Cytisinicline Efficacy or Safety

THOMSON REUTERS
·
Jun 22

Achieve Life Sciences announces annual shareholder meeting

Reuters
·
Jun 09

Achieve Life Sciences director Reid Waldman files initial beneficial ownership statement

Reuters
·
Jun 03

Achieve Life Sciences director Jeffrey S. Farrow files initial beneficial ownership statement

Reuters
·
Jun 03

Achieve Life Sciences adds Jeffrey Farrow, Reid Waldman to board

Reuters
·
Jun 02

Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, Md to Board of Directors

THOMSON REUTERS
·
Jun 02

Press Release: Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors

Dow Jones
·
Jun 02

Achieve Life Sciences announces annual shareholder meeting

Reuters
·
May 30

ADVISORY-Alert wrongly tagged to Achieve Life Sciences withdrawn

Reuters
·
May 28

Achieve Appoints Veteran Banking Executive John Davis as Chief Credit Officer

THOMSON REUTERS
·
May 28

Analysts Conflicted on These Healthcare Names: InMode (INMD), Achieve Life Sciences (ACHV) and BioNTech SE (BNTX)

TIPRANKS
·
May 21

Achieve Life Sciences reports 52-week cytisinicline trial shows no new safety signals

Reuters
·
May 20

Achieve Life Sciences director Martin Christopher Nathan files initial beneficial ownership statement

Reuters
·
May 14

Lake Street Sticks to Its Buy Rating for Achieve Life Sciences (ACHV)

TIPRANKS
·
May 13

Achieve Life Sciences files prospectus for resale of shares by holders

TIPRANKS
·
May 13

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
May 13